表紙
市場調査レポート

眼内黒色腫:世界の治験レビュー

Ocular Melanoma Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 299720
出版日 ページ情報 英文 124 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
眼内黒色腫:世界の治験レビュー Ocular Melanoma Global Clinical Trials Review, H1, 2014
出版日: 2014年03月31日 ページ情報: 英文 124 Pages
概要

当レポートでは、眼内黒色腫に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、概略以下の構成でお届けします。

目次

イントロダクション

  • 眼内黒色腫
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 欧州上位5ヶ国における治験件数
    • 北米の主要国における治験件数

G7諸国での治験件数:腫瘍全体に対する比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験状況

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Delcath Systems, Inc.
  • 代表的な研究機関・病院の治験の概要
    • National Cancer Institute
    • Case Comprehensive Cancer Center
    • USC Norris Comprehensive Cancer Center
    • University of California, Los Angeles
    • Memorial Sloan Kettering Cancer Center
    • Institut Curie
    • European Organization for Research and Treatment of Cancer
    • University of Southern California
    • Thomas Jefferson University
    • Sidney Kimmel Comprehensive Cancer Center

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2067CTIDB

GlobalData's clinical trial report, "Ocular Melanoma Global Clinical Trials Review, H1, 2014" provides data on the Ocular Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ocular Melanoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ocular Melanoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Ocular Melanoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Ocular Melanoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Ocular Melanoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Delcath Systems, Inc.
      • Clinical Trial Overview of Delcath Systems, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
      • USC Norris Comprehensive Cancer Center
      • Clinical Trial Overview of USC Norris Comprehensive Cancer Center
      • University of California, Los Angeles
      • Clinical Trial Overview of University of California, Los Angeles
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Institut Curie
      • Clinical Trial Overview of Institut Curie
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • University of Southern California
      • Clinical Trial Overview of University of Southern California
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • Sidney Kimmel Comprehensive Cancer Center
      • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Ocular Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ocular Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Ocular Melanoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Ocular Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ocular Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Ocular Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ocular Melanoma Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Ocular Melanoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ocular Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Delcath Systems, Inc., 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by USC Norris Comprehensive Cancer Center, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Curie, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014*

List of Figures

  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Ocular Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ocular Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Ocular Melanoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Ocular Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ocular Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Ocular Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ocular Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top